Collin Tokheim

Collin Tokheim

Harvard University

H-index: 21

North America-United States

About Collin Tokheim

Collin Tokheim, With an exceptional h-index of 21 and a recent h-index of 21 (since 2020), a distinguished researcher at Harvard University, specializes in the field of bioinformatics, cancer research, data science, targeted protein degradation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Critical assessment of genome interpretation consortium. CAGI, the critical assessment of genome interpretation, establishes progress and pprospects for computational genetic …

CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods

Pan-cancer proteogenomics connects oncogenic drivers to functional states

Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA

Discovery of targets for immune–metabolic antitumor drugs identifies estrogen-related receptor alpha

Machine learning modeling of protein-intrinsic features predicts tractability of targeted protein degradation

Charting the spatial landscape of cancer hallmarks

Genetic fusions favor tumorigenesis through degron loss in oncogenes

Collin Tokheim Information

University

Position

Research Fellow, Dana-Farber Cancer Institute

Citations(all)

5105

Citations(since 2020)

4463

Cited By

2593

hIndex(all)

21

hIndex(since 2020)

21

i10Index(all)

28

i10Index(since 2020)

27

Email

University Profile Page

Google Scholar

Collin Tokheim Skills & Research Interests

bioinformatics

cancer research

data science

targeted protein degradation

Top articles of Collin Tokheim

Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA

2023/8

Discovery of targets for immune–metabolic antitumor drugs identifies estrogen-related receptor alpha

Cancer discovery

2023/3/1

Machine learning modeling of protein-intrinsic features predicts tractability of targeted protein degradation

Genomics, Proteomics & Bioinformatics

2022/12/6

Charting the spatial landscape of cancer hallmarks

bioRxiv

2022/6/19

Genetic fusions favor tumorigenesis through degron loss in oncogenes

Nature Communications

2021/11/18

In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target

Cell

2021/10/14

Systematic characterization of mutations altering protein degradation in human cancers

Molecular cell

2021/3/18

The genetic evolution of treatment-resistant cutaneous, acral, and uveal melanomas

Clinical Cancer Research

2021/3/1

Determinants of transcription factor regulatory range

Nature communications

2020/5/18

Integrated informatics analysis of cancer-related variants

2020/3

High-throughput prediction of MHC class I and II neoantigens with MHCnuggets

Cancer immunology research

2020/3/1

See List of Professors in Collin Tokheim University(Harvard University)

Co-Authors

academic-engine